Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modifications to Radical Cystectomy and Postoperative Care
NCT06703476Phase 3Recruiting
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2024
- Primary completion
- Nov 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alvimopan in bladder cancer, sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 2024; status: recruiting.
02
Drugs
alvimopan
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT06703476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06703476.